PXD041445-2

PXD041445 is an original dataset announced via ProteomeXchange.

Title	Integrative Proteomics and N-Glycoproteomics Reveals the Synergistic Anti-tumor Effects of Aspirin and Gemcitabine-based Chemotherapy on Pancreatic Cancer Cells
Description	Based on an integrated multi-omics based on quantitative N-glycoproteomes analysis strategy, we investigated their synergistic anti-tumor effects and explored the potential molecular mechanisms and biological functions underlying their inhibitory effects on the development of pancreatic cancer.
HostingRepository	iProX
AnnounceDate	2023-04-10
AnnouncementXML	Submission_2024-06-06_00:49:13.739.xml
DigitalObjectIdentifier
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Unsupported dataset by repository
PrimarySubmitter	Xiaoyu Li
SpeciesList	scientific name: Homo sapiens; NCBI TaxID: 9606;
ModificationList	complex glycosylation; phosphorylation to pyridyl thiol - site S; phosphorylation to amine thiol - site T
Instrument	Orbitrap Exploris 480; Q Exactive HF

Revision	Datetime	Status	ChangeLog Entry
0	2023-04-10 20:05:13	ID requested
1	2023-04-10 20:08:01	announced
⏵ 2	2024-06-06 00:49:15	announced	2024-06-06: Update information.

Li X, Kong R, Hou W, Cao J, Zhang L, Qian X, Zhao L, Ying W, Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-based chemotherapy on pancreatic cancer cells. Cell Oncol (Dordr), 47(1):141-156(2024) [pubmed]

submitter keyword: N-Glycoproteomics, Pancreatic Cancer, Aspirin, Gemcitabine

Wantao Ying
contact affiliation	State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing)
contact email	yingwantao@ncpsb.org.cn
lab head
Xiaoyu Li
contact affiliation	National Center for Protein Sciences (Beijing), Beijing Proteome Research Center, Beijing Institute of Lifeomics
contact email	18611906352@163.com
dataset submitter

iProX dataset URI